2501 - 2525 of 6171 Results
Title
Year
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9990146Citation Count: 53
-
OPENTitle: TikTok Tics: A Pandemic Within a PandemicJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1200End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13316Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8564823Citation Count: 124
-
OPENTitle: A Blueprint for the Conduct of Large, Multisite Trials in TelemedicineJournal Name: Journal of Medical Internet ResearchPublisher: JMIR Publications Inc.Vol: 23Issue #: 9Start Page: e29511End Page: e29511Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/29511Best OA location URL: https://www.jmir.org/2021/9/e29511/PDFCitation Count: 2
-
OPENTitle: A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s diseaseJournal Name: Expert Opinion on Drug DeliveryPublisher: Informa UK LimitedVol: 18Issue #: 11Start Page: 1559End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/17425247.2021.1960820Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1960820?needAccess=trueCitation Count: 14
-
OPENTitle: Advanced Machine Learning Tools to Monitor Biomarkers of Dysphagia: A Wearable Sensor Proof-of-Concept StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 5Issue #: 2Start Page: 167End Page: 175Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000517144Best OA location URL: https://www.karger.com/Article/Pdf/517144Citation Count: 28
-
OPENTitle: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in miceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-24567-xBest OA location URL: https://www.nature.com/articles/s41467-021-24567-x.pdfCitation Count: 9
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8486338Citation Count: 26
-
OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8804990Citation Count: 10
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.07.024Citation Count: 16
-
OPENTitle: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 399End Page: 421Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02349-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02349-5.pdfCitation Count: 21
-
OPENTitle: Distinct progression patterns across Parkinson disease clinical subtypesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1695End Page: 1708Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51436Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51436Citation Count: 7
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8789942Citation Count: 28
-
OPENTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Citation Count: 4
-
OPENTitle: Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02308-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02308-3Citation Count: 33
-
OPENTitle: Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/nxi.0000000000001036Best OA location URL: https://nn.neurology.org/content/nnn/8/5/e1036.full.pdfCitation Count: 87
-
OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2257Citation Count: 15
-
OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8369672Citation Count: 15
-
OPENTitle: The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a RevolutionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1189End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13312Citation Count: 2
-
OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1111/ner.13504Citation Count: 9
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28706Citation Count: 100
- Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life2021OPENTitle: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of lifeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1668End Page: 1679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51424Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51424Citation Count: 9
-
OPENTitle: Temporal trajectory of biofluid markers in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-94345-8Best OA location URL: https://www.nature.com/articles/s41598-021-94345-8.pdfCitation Count: 19
-
OPENTitle: How Will Aducanumab Approval Impact AD Research?Journal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 1End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2021.46Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2021.46.pdfCitation Count: 6
-
OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 7
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 10